REFERENCES
- Gokal R, Mallick NP. Peritoneal dialysis. Lancet. 1999;353:823–828.
- Chiu YW, Mehrotra R. Can we reduce the cardiovascular risk in peritoneal dialysis patients? Indian J Nephrol. 2010;20:59–67.
- Ristić V, Tepsić V, Ristić-Medié D, . Plasma and erythrocyte phospholipid fatty acids composition in Serbian hemodialyzed patients. Ren Fail. 2006;28:211–216.
- Hassan KS, Hassan SK, Hijazi EG. Effects of omega-3 on lipid profile and inflammation markers in peritoneal dialysis patients. Ren Fail. 2010;32:1031–1035.
- Kawashima A, Sugawara S, Okita M, . Plasma fatty acid composition, estimated desaturase activities and intakes of energy and nutrient in Japanese men with abdominal obesity or metabolic syndrome. J Nutr Sci Vitaminol. 2009;55:400–406.
- Oda E, Hatada K, Kimura J. Relationships between serum unsaturated fatty acids and coronary risk factors: Negative relations between nervonic acid and obesity-related risk factors. Int Heart J. 2005;46:975–985.
- Lagerstedt SA, Hinrichs DR, Batt SM. Quantitative determination of plasma C8–C26 total fatty acids for the biochemical diagnosis of nutritional and metabolic disorders. Mol Genet Metab. 2001;73:38–45.
- Haugaard SB, Madsbad S, Hoy CE. Dietary intervention increases n-3 long-chain polyunsaturated fatty acids in skeletal muscle membrane phospholipids of obese subjects. Implications for insulin sensitivity. Clin Endocrinol. 2006;64:169–178.
- Rifai N, Bachorik PS, Albers JJ. Lipids, lipoproteins and apolipoproteins. In: Burtis CA, Ashwood ER, eds. Tietz Textbook of Clinical Chemistry. Philadelphia, PA: W.B. Saunders Company; 1999:843–844.
- de Gómez Dumm NT, Giammona AM, Touceda LA, Raimondi C. Lipid abnormalities in chronic renal failure patients undergoing hemodialysis. Medicina (B Aires). 2001;61:142–146.
- Nakamura N, Fujita T, Kumasaka R, . Serum lipid profile and plasma fatty acid composition in hemodialysis patients – Comparison with chronic kidney disease patients. In Vivo. 2008;22:609–611.
- Dasgupta A, Kenny MA, Ahmad S. Abnormal fatty acid profile in chronic hemodialysis patients: Possible deficiency of essential fatty acids. Clin Physiol Biochem. 1990;8:238–243.
- Girelli D, Lupo A, Trevisan MT, . Red blood cell susceptibility to lipid peroxidation, membrane lipid composition, and antioxidant enzymes in continuous ambulatory peritoneal dialysis patients. Perit Dial Int. 1992;12:205–210.
- Friedman AN, Moe SM, Perkins SM, Li Y, Watkins BA. Fish consumption and omega-3 fatty acid status and determinants in long-term hemodialysis. Am J Kidney Dis. 2006;47:1064–1071.
- Peck LW, Monsen ER, Ahmad S. Effect of three sources of long-chain fatty acids on the plasma fatty acid profile, plasma prostaglandin E2 concentrations, and pruritus symptoms in hemodialysis patients. Am J Clin Nutr. 1996;64:210–214.
- Varga Z, Kárpáti I, Paragh G, Buris L, Kakuk G. Relative abundance of some free fatty acids in plasma of uremic patients: Relationship between fatty acids, lipid parameters, and diseases. Nephron. 1997;77:417–421.
- Simopoulos AP. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med. 2008;233:674–688.
- Kris-Etherton PM, Harris WS, Appel LJ. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Arterioscler Thromb Vasc Biol. 2003;23:20–30.
- Gebauer SK, Psota TL, Harris WS, Kris-Etherton PM. n-3 fatty acid dietary recommendations and food sources to achieve essentiality and cardiovascular benefits. Am J Clin Nutr. 2006;83:1526–1535.
- de Gómez Dumm NT, Giammona AM, Touceda LA, Raimondi C. Lipid abnormalities in chronic renal failure patients undergoing hemodialysis. Medicina. 2001;61:142–146.